Table 2.
The association between RRBP1 expression and clinical-pathological characters was analyzed in PCa
| Clinical-pathological characters | N | RRBP1 | P-value | |
|---|---|---|---|---|
| Low-expression | High-expression | |||
| Age (years) | ||||
| ≤64 | 67 | 16 | 51 | 0.086 |
| >64 | 60 | 23 | 37 | |
| Smoke history | ||||
| Negative | 36 | 9 | 27 | 0.522 |
| Positive | 91 | 30 | 61 | |
| T stage | ||||
| T1–T2 | 75 | 34 | 41 | <0.001 |
| T3–T4 | 52 | 5 | 47 | |
| Lymph node metastasis | ||||
| Negative | 106 | 37 | 69 | 0.021 |
| Positive | 21 | 2 | 19 | |
| PSA (ng/ml) | <0.001 | |||
| ≤20 | 67 | 30 | 37 | |
| >20 | 60 | 9 | 51 | |
| Gleason score | ||||
| <8 | 65 | 31 | 34 | <0.001 |
| ≥8 | 62 | 8 | 54 | |
Abbreviations: RRBP1, ribosome binding protein 1; PCa, prostate cancer.